STEP CHANE PHARMA Trademark

Trademark Overview


On Tuesday, June 18, 2024, a trademark application was filed for STEP CHANE PHARMA with the United States Patent and Trademark Office. The USPTO has given the STEP CHANE PHARMA trademark a serial number of 98606718. The federal status of this trademark filing is NON-FINAL ACTION - MAILED as of Tuesday, January 28, 2025. The STEP CHANE PHARMA trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Step Change Pharma in incorporated in the State of Maryland. It provides consulting services to pharmaceutical companies.
step chane pharma

General Information


Serial Number98606718
Word MarkSTEP CHANE PHARMA
Filing DateTuesday, June 18, 2024
Status641 - NON-FINAL ACTION - MAILED
Status DateTuesday, January 28, 2025
Registration Number0000000
Registration DateNOT AVAILABLE
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateNOT AVAILABLE

Trademark Statements


Goods and ServicesStep Change Pharma in incorporated in the State of Maryland. It provides consulting services to pharmaceutical companies.

Classification Information


International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateTuesday, June 18, 2024
Primary Code044
First Use Anywhere DateTuesday, February 23, 2010
First Use In Commerce DateTuesday, March 23, 2010

Trademark Owner History


Party NameNOT AVAILABLE
Party Type10 - Original Applicant
Legal Entity Type01 - Individual
AddressOlney, MD 20832

Trademark Events


Event DateEvent Description
Tuesday, June 18, 2024NEW APPLICATION ENTERED
Friday, January 10, 2025NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Saturday, January 11, 2025ASSIGNED TO EXAMINER
Tuesday, January 28, 2025NOTIFICATION OF NON-FINAL ACTION E-MAILED
Tuesday, January 28, 2025NON-FINAL ACTION WRITTEN
Tuesday, January 28, 2025NON-FINAL ACTION E-MAILED